Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 20Unknown 5Terminated 4Withdrawn 2Not yet recruiting 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 2Pancreatic Adenocarcinoma 1

Interventions

Gemcitabine 21130-nm albumin-bound paclitaxel 8irinotecan sucrosofate 7Oxaliplatin 7Leucovorin 7Fluorouracil 7Taxes 5Drug Therapy 5Albumin-Bound Paclitaxel 4toripalimab 3Specimen Handling 3S 1 (combination) 3Paclitaxel 3Irinotecan 3Injections 3zimberelimab 2surufatinib 2camrelizumab 2Pemetrexed 2Pancreaticoduodenectomy 2Magnetic Resonance Spectroscopy 2Exercise 2Capecitabine 2Blood Specimen Collection 2Biopsy 2trastuzumab deruxtecan 1sintilimab 1semaglutide 1potassium oxonate 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Pancreatic Neoplasms × Pancreaticoduodenectomy × Clear all
NCT06703905 2024-11-25

Conventional Partial Pancreatoduodenectomy Versus an Extended Pancreatoduodenectomy for Pancreatic Head Cancers

First Affiliated Hospital Xi'an Jiaotong University

Phase NA Not yet recruiting
270 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04847297 2021-04-19

PEAR

University of Pecs

Not yet recruiting
353 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡